Park Circle Company’s AstraZeneca AZN Stock Holding History

Park Circle Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,250	Closed	-$425K	–	99
2020 Q4	$425K	Hold	4,250	–	–	0.4%	43
2020 Q3	$466K	Hold	4,250	–	–	0.52%	39
2020 Q2	$450K	Buy	+4,250	New	+$439K	0.57%	32
2020 Q1	–	Sell	-57,200	Closed	-$5.7M	–	80
2019 Q4	$5.7M	Hold	57,200	–	–	3.84%	7
2019 Q3	$5.1M	Hold	57,200	–	–	2.76%	12
2019 Q2	$4.72M	Hold	57,200	–	–	3.22%	9
2019 Q1	$4.63M	Hold	57,200	–	–	3.27%	9
2018 Q4	$4.34M	Hold	57,200	–	–	3.55%	9
2018 Q3	$4.53M	Hold	57,200	–	–	2.84%	10
2018 Q2	$4.02M	Hold	57,200	–	–	2.62%	11
2018 Q1	$4M	Hold	57,200	–	–	2.48%	13
2017 Q4	$3.97M	Hold	57,200	–	–	2.2%	18
2017 Q3	$3.88M	Hold	57,200	–	–	2.22%	17
2017 Q2	$3.9M	Hold	57,200	–	–	2.18%	14
2017 Q1	$3.56M	Hold	57,200	–	–	2.24%	14
2016 Q4	$3.13M	Hold	57,200	–	–	2.05%	16
2016 Q3	$3.76M	Hold	57,200	–	–	2.6%	11
2016 Q2	$3.45M	Hold	57,200	–	–	2.49%	13
2016 Q1	$3.22M	Hold	57,200	–	–	2.45%	12
2015 Q4	$3.88M	Hold	57,200	–	–	2.6%	10
2015 Q3	$3.64M	Hold	57,200	–	–	2.41%	12
2015 Q2	$3.64M	Hold	57,200	–	–	2.18%	12
2015 Q1	$3.91M	Hold	57,200	–	–	2.55%	10
2014 Q4	$4.03M	Hold	57,200	–	–	2.34%	12
2014 Q3	$4.09M	Hold	57,200	–	–	2.57%	11
2014 Q2	$4.25M	Buy	57,200 +10,000	+21%	+$723K	2.85%	9
2014 Q1	$3.06M	Buy	+47,200	New	+$3.05M	2.26%	13

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Park Circle Company's AZN Position: Q1 2021 in Review

Park Circle Company sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 4,250 shares — an estimated $425K sold.

Park Circle Company first reported a position in AZN in Q1 2014 and held it in 27 quarters. The position peaked at $5.7M in Q4 2019. 755 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

Park Circle Company reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
Park Circle Company sold 4,250 AstraZeneca shares in Q1 2021, an estimated $425K.
Park Circle Company first reported a position in AstraZeneca in Q1 2014 and held it in 27 quarters.
Park Circle Company's AstraZeneca position peaked at $5.7M in Q4 2019.
755 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Park Circle Company's 13F filing for Q1 2021, filed 13 May 2021.